Outlook Pharmaceuticals, Inc. Warning Letter Details

Summary

Based on limited metadata, this FDA Warning Letter issued to Outlook Pharmaceuticals, Inc. on February 21, 2020, concerns violations related to drug products. Without access to the full letter text or subject line details, the specific nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in the metadata provided.